참고문헌
- Ariazi, E.A., Ariazi, J.L., Cordera, F., and Jordan, V.C. (2006). Estrogen receptors as therapeutic targets in breast cancer. Curr. Top. Med. Chem. 6, 195-216 https://doi.org/10.2174/156802606776173474
- Cirino, G. (1998). Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase. Biochem. Pharmacol. 55, 105-111 https://doi.org/10.1016/S0006-2952(97)00215-3
- Delmas, P.D., Bjarnason, N.H., Mitlak, B.H., Ravoux, A.C., Shah, A.S., Huster, W.J., Draper, M., and Christiansen, C. (1997). Effects od raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337, 1641-1647 https://doi.org/10.1056/NEJM199712043372301
- Eming, S.A., Krieg, T., and Davidson, J.M. (2007). Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514-525 https://doi.org/10.1038/sj.jid.5700701
- Esposito, E., Iacono, A., Raso, G..M., Pacilio, M., Coppola, A., Di Cario, R., and Meli, R. (2005). Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats. Endocrinology 146, 3301-3308 https://doi.org/10.1210/en.2005-0375
- Grandage, V.L., Gale, R.E., Linch, D.C., and Khwaja, A. (2005). PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinases and p53 pathways. Leukemia 19, 586- 594 https://doi.org/10.1038/sj.leu.2403653
- Grese, T.A., Sluka, J.P., Bryant, H.U., Cullinan, G.J., Glasebrook, A.L., Jones, C.D., Matsumoto, K., Palkowitz, A.D., Sato, M., Termine, J.D., et al. (1997). Molecular determinants of tissue selectivity in estrogen receptor modulator. Proc. Natl. Acad. Sci. USA 94, 14105-141107-672
- Hanada, T., and Yoshimura, A. (2002). Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13, 413- 421 https://doi.org/10.1016/S1359-6101(02)00026-6
- Katznellenbogen, B.S., and Katznellenbogen, J.A. (2002). Defining the "S" in SERMS. Science 295, 2380-2381 https://doi.org/10.1126/science.1070442
- Kawagoe, J., Ohmichi, M., Takahashi, T., Ohshima, C., Mabuchi, S., Takahashi, K., Igarashi, H., Mori-Abe, A., Saitoh, M., Du, B., et al. (2003). Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line. J. Biol. Chem. 278, 43363-43372 https://doi.org/10.1074/jbc.M304363200
-
Kuiper, G.G.J.M., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., vad der Burg, B., and Gustafsson, J.-A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor-
$\beta$ . Endocrinology 13, 4252-4263 - Laskin, D.L., and Pendino, J. (1995). Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35, 655-677 https://doi.org/10.1146/annurev.pa.35.040195.003255
- Lee, S.J., Bai, S.K., Lee, K.S., Namkoong, S., Na, H.J., Ha, K.S., Han, J.A., Yim, S.Y., Chang, K., Kwon, Y.G., et al. (2003). Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation. Mol. Cells 16, 97-105
- Lonard, D.M., and Smith, C.L. (2002). Molecular perspectives on selective estrogen receptor modulators (SERM): progress in understanding their tissue-specific agonist antagonist actions. Steroid 67, 15-24 https://doi.org/10.1016/S0039-128X(01)00133-7
- Lufkin, E.G., Whitaker, M.D., Nickelsen, T., Argueta, R., Caplan, R.H., Knickerbocker, R.K., and Riggs, B.L. (1998). Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial. J. Bone Miner. Res. 13, 1747-1754 https://doi.org/10.1359/jbmr.1998.13.11.1747
- Romashkova, J.A., and Makarov, S.S. (1999). NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401, 86- 90 https://doi.org/10.1038/43474
- Sherman, M.P., Aeberhard, E.E., Wong, V.Z., Griscavage, J.M., and Ignarro, L.J. (1993). Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 191, 1301-1308 https://doi.org/10.1006/bbrc.1993.1359
- Shoji, T., Yoshida, S., Mitsunari, M., Miyake, N., Tsukihara, S., Iwabe, T., Harada, T., and Terakawa, N. (2007). Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua. J. Reprod. Immunol. 75, 82-90 https://doi.org/10.1016/j.jri.2007.05.002
- Stuehr, D.J. (1997). Structure-function aspects in the nitric oxide synthases, Annu. Rev. Pharmacol. Toxicol. 37, 339-359 https://doi.org/10.1146/annurev.pharmtox.37.1.339
- Suuronen, T., Nuutinen, T., Huuskonen, J., Ojala, J., Thornell, A., and Salminen, A. (2005). Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells. Inflamm. Res. 54, 194-203 https://doi.org/10.1007/s00011-005-1343-z
- Verhaeghe, C., Remouchamps, C., Hennuy, B., Vanderplasschen, A., Chariot, A., Tabruyn, S.P., Oury, C., and Bours, V. (2007). Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem. Pharmacol. 73, 1982-1994 https://doi.org/10.1016/j.bcp.2007.03.019